Can virus therapy of human cancer be improved by apoptosis induction?
Direct virus inoculations and viral oncolysates may induce temporary remissions and prolong life with reduced tumor burden, or decrease relapse rates but fall short of curing human cancers. We propose: (i) investigations of Cassel's 73-T, an Ehrlich's mouse ascites carcinoma-adapted Newcastle disease virus (NDV) strain that so effectively reduced relapse rates in malignant melanoma if it is an admixture or a recombinant with a murine parvovirus; (ii) transfection of prostatic carcinoma cells with the TRMP gene; (iii) transfection of sarcoma cells with the fas gene followed by treatment with anti-fas monoclonal antibodies, and (iv) treatment of metastatic tumors with a parvovirus incorporating the apoptosis-inducer Ad5 E1A gene.Thus, replicating virions and haphazard generation of cytokines in the inoculated host could be replaced with transfection of single genes of well-defined, limited but selected efficacy.
Sinkovics
J G
JG
St Joseph's Hospital, Department of Medicine, University of South Florida College of Medicine, Tampa 33677-4227, USA.
Horvath
J
J
D017500:Adenovirus E1A Proteins / Q000235:genetics; D000260:Adenoviruses, Human / Q000235:genetics; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D017209:Apoptosis; D005814:Genes, Viral; D015316:Genetic Therapy; D006801:Humans; D008297:Male; D008545:Melanoma / Q000628:therapy; D051379:Mice; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000150:complications / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy*; D009857:Oncogenes; D017992:Parvovirus / Q000276:immunology; D011471:Prostatic Neoplasms; D012509:Sarcoma; D014162:Transfection; D014407:Tumor Cells, Cultured; D014614:Vaccines, Synthetic / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use*; D014777:Virus Diseases / Q000150:complications; D019014:fas Receptor / Q000096:biosynthesis / Q000276:immunology
D017500:Adenovirus E1A Proteins; D000911:Antibodies, Monoclonal; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; D019014:fas Receptor